LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome

被引：9
|
作者：
Field, Patrick A. [1 ,2 ]
Vasan, Ramachandran S. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Boston Univ, Boston, MA 02215 USA
[2] NHLBI, Framingham Study, Framingham, MA USA
[3] Boston Univ, Sch Med, Sect Prevent Med & Epidemiol, Dept Epidemiol, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Sect Cardiovasc Med, Dept Epidemiol, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Sect Prevent Med & Epidemiol, Dept Epidemiol, Boston, MA 02118 USA
[6] Boston Univ, Sch Publ Hlth, Sect Cardiovasc Med, Dept Epidemiol, Boston, MA 02118 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 104卷 / 02期
关键词：
CARDIOVASCULAR RISK;
D O I：
10.1002/cpt.1126
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Coronary artery disease (CAD) is a progressive disorder and its risk is best determined using multiple biomarkers and risk factors. Many novel biomarkers have been shown to improve cardiovascular disease risk beyond that of the traditional risk factors, including polygenic risk scores, small very low-density lipoprotein (VLDL), ApoB, triglycerides (TG), non-HDL-c, lipoprotein (a) (Lp(a)), coronary calcium scores, C-reactive protein (CRP), B-type natriuretic peptide (BNP), troponins, and many other novel biomarkers that have been measured using high throughput assays.
引用
收藏
页码：232 / 234
页数：3
相关论文
共 50 条
  • [31] Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease
    Ghosh J.
    Mishra T.K.
    Rao Y.N.
    Aggarwal S.K.
    Indian Journal of Clinical Biochemistry, 2006, 21 (1) : 181 - 184
  • [32] White blood cell count combined with LDL cholesterol as a valuable biomarker for coronary artery disease
    Liu, Zhiyun
    Yan, Yongjin
    Gu, Shunzhong
    Lu, Yang
    He, Hao
    Ding, Hongsheng
    CORONARY ARTERY DISEASE, 2023, 34 (06) : 425 - 431
  • [33] Association of small dense LDL-cholesterol with disease severity, hypertension status and clinical outcome in patients with coronary artery disease
    Zhang, Hui-Wen
    Jin, Jing-Lu
    Cao, Ye-Xuan
    Liu, Hui-Hui
    Zhang, Yan
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Gao, Ying
    Xu, Rui-Xia
    Hua, Qi
    Li, Yan-Fang
    Cui, Chuan-Jue
    Dong, Qian
    Sun, Jing
    Li, Jian-Jun
    JOURNAL OF HYPERTENSION, 2021, 39 (03) : 511 - 518
  • [34] Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
    Zhang, Wenduo
    Ji, Fusui
    Yu, Xue
    Wang, Xinyue
    MEDICINE, 2017, 96 (01)
  • [35] LDL-CHOLESTEROL TARGETS IN PATIENTS WITH CORONARY HEART DISEASE IN EXTREMADURA: LYNX REGISTRY
    Gomez-Barrado, J. J.
    Gomez-Turegano, P.
    Vega Fernandez, J.
    Porras Ramos, Y.
    Ortiz Cortes, C.
    Mogollon Jimenez, M. V.
    Kounka, Z.
    Lezcano Gort, L. E.
    Romero Castro, M. J.
    Chipayo Gonzales, D.
    Perez-Espejo, P.
    Roque Rodriguez, B.
    Fernandez-Chamorro, A. I.
    Beltran Moreno, M.
    ATHEROSCLEROSIS, 2020, 315 : E194 - E195
  • [36] Looking beyond LDL-cholesterol: the emerging role of triglycerides in coronary heart disease
    Assman, G
    ATHEROSCLEROSIS, 1998, 136 : S35 - S36
  • [37] Apolipoprotein B and LDL-cholesterol: which parameter(s) should be routinely assayed to assess coronary artery disease?
    Bloch, S
    Couderc, R
    ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 (05) : 539 - 544
  • [38] Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease
    Tada, Hayato
    Kawashiri, Masa-aki
    Nomura, Akihiro
    Teramoto, Ryota
    Hosomichi, Kazuyoshi
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Tajima, Atsushi
    Yamagishi, Masakazu
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (06) : 1436 - 1444
  • [39] HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
    Meikle, Peter J.
    Formosa, Melissa F.
    Mellett, Natalie A.
    Jayawardana, Kaushala S.
    Giles, Corey
    Bertovic, David A.
    Jennings, Garry L.
    Childs, Wayne
    Reddy, Medini
    Carey, Andrew L.
    Baradi, Arul
    Nanayakkara, Shane
    Wilson, Andrew M.
    Duffy, Stephen J.
    Kingwell, Bronwyn A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (11):
  • [40] Oligogenic Familial Hypercholesterolemia, LDL Cholesterol, and Coronary Artery Disease
    Tada, Hayato
    Kawashiri, Masa-aki
    Nomura, Akihiro
    Teramoto, Ryota
    Hosomichi, Kazuyoshi
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Tajima, Atsushi
    Yamagishi, Masakazu
    CIRCULATION, 2017, 136
12345